TA

Tatva Chintan Pharma Chem LtdNSE TATVA Stock Report

Last reporting period 31 Mar, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.548

Micro

Exchange

XNSE - National Stock Exchange Of India

TATVA.NS Stock Analysis

TA

Uncovered

Tatva Chintan Pharma Chem Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.548

Dividend yield

0.41 %

Shares outstanding

23.392 B

Tatva Chintan Pharma Chem Ltd. is a chemicals manufacturing company. The company is headquartered in Vadodara, Gujarat and currently employs 608 full-time employees. The company went IPO on 2021-07-29. The firm is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The firm operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The firm is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.

View Section: Eyestock Rating